John David Finley - Oct 3, 2023 Form 4 Insider Report for PALISADE BIO, INC. (PALI)

Signature
/s/ JD Finley
Stock symbol
PALI
Transactions as of
Oct 3, 2023
Transactions value $
-$218
Form type
4
Date filed
10/5/2023, 05:46 PM
Previous filing
Sep 29, 2023
Next filing
Nov 8, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PALI Common Stock, par value $0.01 Options Exercise $0 +1.31K +3.02% $0.00 44.7K Oct 3, 2023 Direct F1
transaction PALI Common Stock, par value $0.01 Tax liability -$218 -397 -0.89% $0.55 44.3K Oct 4, 2023 Direct F2
holding PALI Common Stock, par value $0.01 777 Oct 3, 2023 By FCW Investments, LLC F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PALI Restricted Stock Units Options Exercise -1.31K -50% 1.31K Oct 3, 2023 Common Stock 1.31K Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents the right to receive, at settlement, one share of common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date.
F2 Represents shares sold on behalf of Reporting Person to satisfy tax requirements related to the vesting of the restricted stock units.
F3 Reporting Person is the managing member of FCW Investments LLC and has the sole investment and voting power over the securities held by this entity.
F4 This restricted stock unit was granted on January 3, 2023, and 1,309 restricted stock units subject to the award vested on October 4, 2023, and an additional 1,309 restricted stock units will vest on January 3, 2024, subject to Reporting Person continuing to be a service provider to Issuer at the time of vesting.